News Focus
News Focus
icon url

$heff

07/29/13 9:19 AM

#70042 RE: $heff #70041

CHTP..the FDA has identified certain technical deficiencies in the NDA resubmission that will require resolution.

http://www.marketwatch.com/story/chelsea-therapeutics-announces-update-to-northeratm-droxidopa-nda-filing-2013-07-29